hookipapharma.com - HOOK Net Assets per Single Share

Graphic logo of HOOKIPA Pharma (HOOK)

Through partnerships with industry behemoths, HOOKIPA Pharma Inc. (HOOK) ensures balance sheet liquidity and covers R&D costs. Net assets per share reflect capital dynamics, with the current level standing at 2.70. The business value depends on scientific breakthroughs in oncology rather than economic cycles. The company is currently optimizing expenses, focusing on the development of HPV vaccines.

HOOKIPA (HOOK): Share Book Value from 07/04/2022 to 08/24/2025

HOOKIPA Pharma, Inc. - analytical breakdowns and key metrics (HOOK)

- price and consensus price forecast:
Price Chart HOOKIPA|HOOK - Average Forecast Price
- market capitalization data:
Market Value HOOKIPA Pharma Inc.|HOOK - Enterprise Value
- book capitalization data:
Net Assets per Single Share HOOKIPA Pharma|HOOK - Net Asset Value|Market Capitalization to Book Value Ratio hookipapharma.com|HOOK - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital HOOKIPA Pharma Inc.|HOOK - Long-Term Debt to Capital|Short-Term Debt to Equity HOOKIPA|HOOK - Aggregate Debt Obligations|Debt to Book Capitalization Ratio HOOKIPA Pharma Inc.
Fundamental company valuation:hookipapharma.com - HOOK
Manufactured products of HOOKIPA

Institutional capital assesses the resilience of HOOKIPA Pharma Inc. (HOOK) through equity dynamics, accounting for ESG modernization costs for laboratories and energy-saving systems. By analyzing this BVPS valuation, an investor identifies the residual asset value per share after deducting all liabilities, which enables the determination of the business's intrinsic value and protects investments from capital dilution.

Competitors of HOOKIPA Pharma Inc. (HOOK)

ARGX (Argenx) - Net Assets per Single Share|BNTX: Net Asset Value per Share|ABVX: Net Assets per Single Share|ADMA (admabiologics.com) - Book Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Book Value per Share Astria Pharma (ATXS)|ENGN: Accounting Value of a Share|Net Assets per Single Share RAPT|JBIO (Aerovate Therapeutics) - Net Asset Value per Share|Net Assets per Single Share ACRS (Aclaris Therapeutics, Inc.)|Net Asset Value per Share KYTX|Net Assets per Single Share TLSA|Book Value per Share Cabaletta Bio Inc (CABA)|Book Value per Share VTYX|theratech.com - Net Assets per Share|Net Assets per Single Share Avalo Therapeutics|ELDN - Share Book Value|AGEN: Book Value per Share|Book Value per Share Climb Bio, Inc|ZURA - Accounting Value per Share|Accounting Value of a Share ATYR|ADAG - Net Assets per Single Share|Share Book Value ikenaoncology.com (IMA)|Book Value per Share Shattuck Labs|Accounting Value of a Share Equillium Inc EQ|Connect Pharma - Book Value per Share|IMUX: Book Value per Share|Net Assets per Single Share atarabio.com ATRA|IFRX (InflaRx) - Accounting Value of a Share|Net Assets per Single Share XFOR|Accounting Value per Share Adicet|Book Value per Share CELU|Book Value per Share inmunebio.com INMB|Accounting Value per Share Barinthus Biotherapeutics plc|Accounting Value of a Share Kezar Life Sciences Inc. KZR|Book Value per Share SABS (SAB Biotherapeutics, Inc)|AKTX: Net Assets per Share|Net Assets per Single Share enlivex.com|Q32 Bio (QTTB) - Equity per Share|Book Value per Share GOVX|Accounting Value per Share Edesa Biotech Inc (EDSA)|IBIO (iBio Corp) - Accounting Value per Share|Net Assets per Share carismatx.com (CARM)|Book Value per Share XTL Biopharmaceuticals|Bolt Biotherapeutics Inc. - Accounting Value of a Share|HCWB (HCW Biologics Inc) - Net Assets per Single Share|APVO: Net Asset Value per Share|Net Assets per Single Share AIM|ADTX (Aditxt, Inc.) - Net Asset Value per Share|GRI (GRI Bio, Inc.) - Net Assets per Single Share|Book Value per Share XRTX|HIND - Net Assets per Single Share|Share Book Value Revelation Biosciences Inc (REVB)|Book Value per Share Indaptus|Accounting Value of a Share BiondVax Pharmaceuticals SCNI|CalciMedica Corp - Book Value per Share|AFMD: Book Value per Share|Net Assets per Single Share allakos.com ALLK|IGMS (IGM Biosciences) - Accounting Value of a Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share thirdharmonicbio.com THRD